Pharmexcil Eyes USD 1.4 Billion Pharma Exports as iPHEX 2026 Opens New Global Markets
600+ overseas business delegates to engage with Indian pharma companies as Pharmexcil looks to translate global buyer participation into new markets and commercial opportunities.
- Industrial talks | 04/09/2026 | By News Bureau
Interviews
Rishad Dadachanji, Director, Kairish Innotech
Rishad Dadachanji, Director, Kairish Innotech, discusses pharmaceutical automation, engineering excellence, regulatory compliance, and the future of smart manufacturing, in an exclusive interview with Pharma Industr...
Dr. Seema Pai, President, Indian Society for Clinical Research (ISCR)
Dr. Seema Pai, President, Indian Society for Clinical Research (ISCR), speaks exclusively to Pharma Industrial India on India’s growing global role in clinical research, regulatory excellence, technology adopt...
Sachin Joshi, Managing Director and Co-Founder, PharmNXT
Sachin Joshi, Managing Director and Co-Founder, PharmNXT, discusses biologics supply chains, single-use technologies, localisation, and the future of biologics manufacturing, in an exclusive interview with Pharma In...
Articles
Beyond Manufacturing: Advancing Biopharma Innovation through India-US Strategic Collaboration
India has emerged as a global pharmaceutical manufacturing hub, but transforming into an innovation-led ecosystem will require stronger policy reforms and deeper India-US collaboration...
Building the Future of Pharma with AI CoEs and Predictive Manufacturing
Artificial Intelligence (AI) Centers of Excellence (CoEs), predictive manufacturing, and digital twins are reshaping pharma operations by enabling smarter, connected, and future-ready manufacturing ecosystems....
Why India Must Invest More in Novel Drug Discovery
India’s pharma industry must shift from volume to value by investing in novel drug discovery, innovation, and research and development (R&D) to drive global leadership and sustainable growth....
Blog
Building a Resilient Pharma Supply Chain in India: Challenges, Innovations and the Road Ahead
By Darshana Daga
PRIP Scheme Set for Rollout: Key Highlights of the INR 5,000 Cr Initiative
By Pharma Industrial India
Latest news in...
Clinical Trials
Next events
Appointments
Saumen Chakraborty, Member Board of Directors, PREMAS BIOTECH
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Silvia Steyrer-Grube, Chief Executive Officer, CEO, Coriolis Pharma
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy